| (USD) | Jun 2025 | Y/Y change |
|---|---|---|
| Revenue | 55.04M | -0.28% |
| Operating expense | — | — |
| Net income | -40.13M | -0.21% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, AGYTF returned +76.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +36.4% |
| 1 year | +76.5% |
| 5 years | -64.3% |
| 10 years | -66.7% |
| All-time high | $0.51 (Nov 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in AGYTF would be worth today ›No. Allergy Therapeutics plc has not paid a dividend in the past 12 months.
Allergy Therapeutics plc is part of the Healthcare sector.
Allergy Therapeutics plc has a market cap of 949.88M USD, based on the latest quote.
